Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome
Status:
Not yet recruiting
Trial end date:
2021-09-29
Target enrollment:
Participant gender:
Summary
The aim of the study is to demonstrate a significant improvement in quality of life specific
to patients with fibromyalgia syndrome in patients with fibromyalgia syndrome with comorbid
posttraumatic stress disorder, treated with reconsolidation blockade.
Patients receive a treatment with propranolol associated with reconsolidation blockade of
traumatic story once a week during 6 weeks, with evaluation at inclusion and at 3 months.